Immune System and Its Disorders in Children with Down Syndrome
DOI:
https://doi.org/10.5281/zenodo.16585357Keywords:
Down syndrome, immunity, immunodeficiencyAbstract
Down syndrome is caused by extra genetic material from chromosome 21 and occurs in all ethnic groups and in different species. There are many comorbidities associated with Down syndrome, including developmental delay, congenital heart disease, gastrointestinal anomalies, increased risk of hematologic malignancies and various autoimmune conditions. It is also the most common genetic syndrome associated with immune deficiencies in which both innate and adaptive responses are affected. Defects in immunologic parameters have been identified in Down Syndrome and have been proposed as the cause of the increased severity of infections in children with Down Syndrome. Most of these infections occur in the respiratory tract, suggesting anomalies in humoral immunity. However, differences in immune responses have been reported, including mild to moderately reduced T and B cell counts, lack of normal lymphocyte proliferation during infancy, smaller thymus size compared to age group, mild to moderately reduced percentages of naive T cells and correspondingly reduced Treg cell counts, suboptimal antibody responses to vaccination, reduced total and specific immunoglobulin A in saliva, and reduced neutrophil chemotaxis. In this article, defects in different components of the immune system in patients with Down syndrome and their clinical implications will be discussed.
Downloads
References
Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004–2006. Birth Defects Res A Clin Mol Teratol. 2010;88:1008–16.
Ni She R, Filan PM. Trisomy 21–incidence and outcomes in the first year, in Ireland today. Ir Med J. 2014;107:248–9.
van Trotsenburg AS, Heymans HS, Tijssen JG, de Vijlder JJ, Vulsma T. Comorbidity, hospitalization, and medication use and their influence on mental and motor development of young infants with Down syndrome. Pediatrics. 2006;118:1633–9.
Cruz NV, Mahmoud SA, Chen H, Lowery-Nordberg M, Berlin K, Bahna SL. Follow-up study of immune defects in patients with dysmorphic disorders. Ann Allergy Asthma Immunol. 2009;102:426–31.
Valentini D, Di Camillo C, Mirante N, Marcellini V, Carsetti R, Villani A. Effects of Pidotimod on recurrent respiratory infections in children with Down syndrome: a retrospective Italian study. Ital J Pediatr. 2020;46(1):31.
Fitzgerald P, Leonard H, Pikora TJ, Bourke J, Hammond G. Hospital admissions in children with down syndrome: experience of a population-based cohort followed from birth. PLoS ONE. 2013;8:e70401.
Lee YI, Peng CC, Chiu NC, Huang DT, Huang FY, Chi H. Risk factors associated with death in patients with severe respiratory syncytial virus infection. J Microbiol Immunol Infect. 2016;49:737–42.
Garrison MM, Jeffries H, Christakis DA. Risk of death for children with down syndrome and sepsis. J Pediatr. 2005;147:748–52.
Joshi AY, Abraham RS, Snyder MR, Boyce TG. Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency? Vaccine. 2011;29:5040–6.
Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164:9–16.
Kusters MA, Verstegen RH, Gemen EF, de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol. 2009;156:189–93.
de Hingh YC, van der Vossen PW, Gemen EF, et al. Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005;147:744–7.
Roat E, Prada N, Lugli E, et al. Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome. Rejuvenation Res. 2008;11:573–83.
Kondelkova K, Vokurkova D, Krejsek J, Borska L, Fiala Z, Ctirad A. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med. 2010;53:73–7.
Marcovecchio GE, Bortolomai I, Ferrua F, et al. Thymic epithelium abnormalities in DiGeorge and Down syndrome patients contribute to dysregulation in T cell development. Front Immunol. 2019;10:447.
Verstegen RH, Kusters MA, Gemen EF, DE Vries E. Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res. 2010;67(5):563-9.
Carsetti R, Valentini D, Marcellini V, et al. Reduced numbers of switched memory B cells with high terminal differentiation potential in Down syndrome. Eur J Immunol. 2015;45:903–14.
Baumjohann D, Preite S, Reboldi A, et al. Persistent antigen and germinal center B cells sustain T follicular helper cell responses and phenotype. Immunity. 2013;38:596–605.
Valentini D, Marcellini V, Bianchi S, et al. Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. Vaccine. 2015;33:6689–96.
Schoch J, Rohrer TR, Kaestner M, et al. Quantitative, phenotypical, and functional characterization of cellular immunity in children and adolescents with Down syndrome. J Infect Dis. 2017;215:1619–28.
Verstegen RHJ, Kusters MAA. Inborn Errors of Adaptive Immunity in Down Syndrome. J Clin Immunol. 2020;40(6):791-806.
Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet. 2010;37:233–7.
Huggard D, Doherty DG, Molloy EJ. Immune dysregulation in children with Down syndrome. Front Pediatr. 2020;8:73.
Lagan N, Huggard D, Mc Grane F, et al. Multiorgan involvement and management in children with Down syndrome. Acta Paediatr. 2020;109(6):1096-111.
Gemen EF, Verstegen RH, Leuvenink J, de Vries E. Increased circulating apoptotic lymphocytes in children with Down syndrome. Pediatr Blood Cancer. 2012;59:1310–2.
Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, Wong SC. The three human monocyte subsets: implications for health and disease. Immunol Res. 2012;53:41–57.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Lütfi Kılınçkaya, Öner

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.




